Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00076973
Status:
COMPLETED
Last Update Posted:
2022-02-02
First Post:
2004-02-06
Brief Title:
An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus RSV Bronchiolitis 0476-272
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
A Randomized 2-Period Multicenter Dble-Blind Parallel-Group Study Comparing Effects of 2 Doses of MK0476 and Placebo in the Tx of Respiratory Symptoms Associated w Respiratory Syncytial Virus-Induced Bronchiolitis in Children 3 to 24 Mths
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to look at whether an investigational drug can treat the breathing symptoms of RSV bronchiolitis in children 3 to 24 months of age
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004_098 | None | None | None |
| Formerly 0112BRS | None | None | None |
| MK0476-272 | None | None | None |